gvtcx

Provision of SCID Screening Assay Kits

NHS England Published 29 Jul 2025 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£310,000
Statuscomplete
Category (CPV) 85100000
Deadline31 Mar 2025
Contract start1 Apr 2025
Contract end30 Sept 2025
Procedureselective
SME suitableYes
OCIDocds-b5fd17-3de3e604-4e30-4129-8669-cd77fa40f9b7

Award

SupplierValueDateStatus
Revvity (UK) Limited £310,000 13 Jul 2025 active

description

A call off under National Microbiology Framework for the EONIS Q Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in Screening laboratories to Revvity.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
29 Jul 2025 Award (award) · 7ee11c14-1da6-4e37-8db5-2c7b418c9f1d-856553

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.